Description
Unit: 1 Box (20 Tests)
Regulatory Status: CLIA Waived (Nasal Swab) / Moderately Complex (Nasal Wash / Nasal Aspirate) / Professional Use Only
Contents: (20)Individually Packaged Test Devices, (20) Individually Packaged Nasopharyngeal Swabs, (20) Extraction Tubes, (20) Specimen
Processing Tubes, (20) Sterile Normal Saline Vials, (40) Disposable Pipettes, (2.0) mL R1 (Extraction Reagent Solution), (1) 1.0 mL PC
(Positive Control Reagent) &, Instructions for Use
Determinations: Qualitative Respiratory Syncytial Virus (RSV)
Storage Requirements: 59° – 86° F
Processing Time: 15 Minutes
The Clarity Diagnostics RSV Antigen test is designed for the qualitative detection of respiratory syncytial virus antigen fusion protein directly from nasopharyngeal swab or nasal aspirate specimens. The kit includes all components to run a nasopharyngeal specimen, no additional components necessary.
Proudly made in the USA!
About RSV
The RSV virus is an enveloped, non-segmented, negative-sense RNA virus classified in the subfamily Pneumovirinae of the Paramyxoviridae family. Virus replication begins in the nasopharynx, then replicates principally in the superficial layer of the respiratory epithelium and then spreads downward into the lower respiratory tract through the inhalation of secretions. This causes inflammation of the bronchioles resulting in wheezing, difficulty breathing, and sometimes respiratory failure.
Respiratory syncytial virus is spread easily through inhalation of virus-laden aerosolized particles (produced by normal breathing, speaking, singing, coughing, or sneezing ), direct contact with infected individuals, or contact with contaminated objects. The virus can linger on surfaces for up to eight hours and can be contagious for up to 8 days. Infections normally occur in the US between November and April. Infection can occur at all ages, but can be more critical in premature infants; children with chronic lung disease, congenital heart disease, or immune system deficiencies; and adults over the age of 65.
The typical RSV infection causes mild, cold-like symptoms in adults and healthy school-aged children. Symptoms tend to appear 4-6 days after exposure and include a coughing, sneezing, stuffy and/or runny nose, fever, and a decreased appetite. These symptoms normally diminish in 7 to 14 days, but the cough may linger for weeks. Complications with RSV that can occur in higher risk patients include croup, ear infections, and pneumonia. There is no treatment option for RSV viral infections. Mild infections resolve on their own. However, supportive care can be used in the form of bronchiodilators (to keep airways open), humidifiers, and over-the-counter medications to relieve symptoms.
For more severe cases and high-risk patients, doctors may prescribe an antiviral medication. Antiviral medications can be used to effectively reduce the intensity and duration of symptoms, but they cannot treat or prevent infection of RSV. These medications work best if the patient begins taking them at early on-set of symptoms. The QuickVue RSV Test combines testing, diagnosis, and symptom management all in the same doctor’s visit, which could reduce the potential for serious complications.
